The firm's drug candidates include SynCon immunotherapies which helps break the immune system’s... Data are provided 'as is' for informational purposes only and are not intended for trading purposes.
Historical daily share price chart and data for Inovio Pharmaceuticals since 1998 adjusted for splits.
The price target represents a potential 16% downside from Inovio's previous closing price on Monday of $18.99. Barron's also provides information on historical stock ratings, target prices… Inovio Pharmaceuticals Inc is crashing on Tuesday, trading around $15 after its earnings call. Copyright 2020 FactSet Research Systems Inc. All rights reserved. View the latest Inovio Pharmaceuticals Inc. (INO) stock price, news, historical charts, analyst ratings and financial information from WSJ.
View today's stock price, news and analysis for Inovio Pharmaceuticals Inc. (INO). ... Price/Sales: 79.23: Price/Book: 596.64: Competitors Today’s change Today’s Inovio Pharmaceuticals stock price prediction is an act of determining the future value of Inovio Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Inovio Pharmaceuticals stock future price could yield a significant profit. Stifel analysts cut their stock price target for Inovio Pharmaceuticals Inc. INO, -6.08% to $16 from $24 on Tuesday, after the company posted a wider …
In the second quarter, Inovio saw revenue rise … The latest closing stock price for Inovio Pharmaceuticals as of August 07, 2020 is 20.22..
Dive deeper with interactive charts and top stories of INOVIO PHARMACEUTICALS, INC..
Source: FactSet FundamentalsInovio Pharmaceuticals, Inc. is a late-stage biotechnology company. Shares of the pharmaceutical company shed 12% in premarket trading Tuesday.
The all-time high Inovio Pharmaceuticals stock closing price was 191.04 on March 03, 2000.; The Inovio Pharmaceuticals 52-week high stock price is 33.79, which is 67.1% above the current share price. View the latest INO stock quote and chart on MSN Money. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news and financial information from CNBC. Stock analysis for Inovio Pharmaceuticals Inc (GBMB:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Update : NASDAQ: INO is changing hands at around $15 – a fall of around 20% from Monday's close.
Inovio Pharmaceuticals reported quarterly earnings results Monday that missed Wall Street's expectations. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines.
Data may be intentionally delayed pursuant to supplier requirements. Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company.